Structure

Physi-Chem Properties

Molecular Weight:  470.34
Volume:  517.825
LogP:  5.586
LogD:  3.369
LogS:  -4.481
# Rotatable Bonds:  5
TPSA:  77.76
# H-Bond Aceptor:  4
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.413
Synthetic Accessibility Score:  5.068
Fsp3:  0.767
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.232
MDCK Permeability:  2.609351031424012e-05
Pgp-inhibitor:  0.374
Pgp-substrate:  0.012
Human Intestinal Absorption (HIA):  0.015
20% Bioavailability (F20%):  0.032
30% Bioavailability (F30%):  0.617

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.029
Plasma Protein Binding (PPB):  96.61345672607422%
Volume Distribution (VD):  0.828
Pgp-substrate:  2.9284584522247314%

ADMET: Metabolism

CYP1A2-inhibitor:  0.01
CYP1A2-substrate:  0.141
CYP2C19-inhibitor:  0.017
CYP2C19-substrate:  0.914
CYP2C9-inhibitor:  0.096
CYP2C9-substrate:  0.972
CYP2D6-inhibitor:  0.001
CYP2D6-substrate:  0.146
CYP3A4-inhibitor:  0.1
CYP3A4-substrate:  0.19

ADMET: Excretion

Clearance (CL):  3.284
Half-life (T1/2):  0.254

ADMET: Toxicity

hERG Blockers:  0.087
Human Hepatotoxicity (H-HT):  0.789
Drug-inuced Liver Injury (DILI):  0.006
AMES Toxicity:  0.004
Rat Oral Acute Toxicity:  0.294
Maximum Recommended Daily Dose:  0.89
Skin Sensitization:  0.945
Carcinogencity:  0.057
Eye Corrosion:  0.005
Eye Irritation:  0.071
Respiratory Toxicity:  0.973

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC222845

Natural Product ID:  NPC222845
Common Name*:   3Alpha,16Alpha-Dihydroxylanosta-7,9(11),24-Trien-21-Oic Acid
IUPAC Name:   (2R)-2-[(3R,5R,10S,13R,14R,16R,17R)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid
Synonyms:  
Standard InCHIKey:  XSLKAKROJKMHIT-HBZKPHNJSA-N
Standard InCHI:  InChI=1S/C30H46O4/c1-18(2)9-8-10-19(26(33)34)25-22(31)17-30(7)21-11-12-23-27(3,4)24(32)14-15-28(23,5)20(21)13-16-29(25,30)6/h9,11,13,19,22-25,31-32H,8,10,12,14-17H2,1-7H3,(H,33,34)/t19-,22-,23+,24-,25+,28-,29-,30+/m1/s1
SMILES:  CC(=CCC[C@H]([C@H]1[C@H](O)C[C@@]2([C@]1(C)CC=C1C2=CC[C@@H]2[C@]1(C)CC[C@H](C2(C)C)O)C)C(=O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL496839
PubChem CID:   16083192
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO7904 Ganoderma applanatum Species Polyporaceae Eukaryota n.a. n.a. n.a. DOI[10.1016/S0031-9422(00)91122-1]
NPO7904 Ganoderma applanatum Species Polyporaceae Eukaryota n.a. Sri Lankan n.a. PMID[16933889]
NPO7904 Ganoderma applanatum Species Polyporaceae Eukaryota n.a. n.a. n.a. PMID[27996259]
NPO7904 Ganoderma applanatum Species Polyporaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO7904 Ganoderma applanatum Species Polyporaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO7904 Ganoderma applanatum Species Polyporaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT168 Cell Line P388 Mus musculus Activity > 125.0 ug ml-1 PMID[510321]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC222845 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC45324
1.0 High Similarity NPC162001
0.967 High Similarity NPC186810
0.967 High Similarity NPC477813
0.967 High Similarity NPC48647
0.9659 High Similarity NPC23434
0.9551 High Similarity NPC152897
0.9551 High Similarity NPC66429
0.9551 High Similarity NPC470376
0.9551 High Similarity NPC470375
0.9432 High Similarity NPC77168
0.9432 High Similarity NPC102414
0.9432 High Similarity NPC84271
0.9341 High Similarity NPC263347
0.9341 High Similarity NPC69548
0.9341 High Similarity NPC184848
0.9326 High Similarity NPC46281
0.9318 High Similarity NPC247406
0.9318 High Similarity NPC48866
0.9239 High Similarity NPC155676
0.9231 High Similarity NPC469406
0.9213 High Similarity NPC54689
0.9205 High Similarity NPC159046
0.9205 High Similarity NPC233836
0.9205 High Similarity NPC187376
0.9205 High Similarity NPC312215
0.9167 High Similarity NPC477812
0.9111 High Similarity NPC123854
0.9101 High Similarity NPC294480
0.9101 High Similarity NPC242864
0.9091 High Similarity NPC28252
0.9091 High Similarity NPC212843
0.9091 High Similarity NPC55309
0.9032 High Similarity NPC173272
0.9022 High Similarity NPC49670
0.9011 High Similarity NPC154101
0.9011 High Similarity NPC45269
0.9011 High Similarity NPC297265
0.9 High Similarity NPC474704
0.9 High Similarity NPC475921
0.8989 High Similarity NPC142361
0.8989 High Similarity NPC474684
0.8925 High Similarity NPC48330
0.8913 High Similarity NPC243866
0.8901 High Similarity NPC175628
0.8901 High Similarity NPC469400
0.8901 High Similarity NPC111585
0.8901 High Similarity NPC148414
0.8889 High Similarity NPC183546
0.8817 High Similarity NPC7165
0.8804 High Similarity NPC110657
0.8804 High Similarity NPC212301
0.8804 High Similarity NPC26888
0.8804 High Similarity NPC189520
0.8804 High Similarity NPC86266
0.8791 High Similarity NPC474889
0.8791 High Similarity NPC155479
0.8723 High Similarity NPC469599
0.8723 High Similarity NPC20546
0.871 High Similarity NPC141497
0.871 High Similarity NPC107674
0.871 High Similarity NPC170220
0.871 High Similarity NPC470224
0.8696 High Similarity NPC471896
0.8667 High Similarity NPC94755
0.8667 High Similarity NPC155011
0.8646 High Similarity NPC235464
0.8646 High Similarity NPC166745
0.8632 High Similarity NPC95565
0.8617 High Similarity NPC111015
0.8617 High Similarity NPC166906
0.8586 High Similarity NPC472227
0.8586 High Similarity NPC472228
0.8571 High Similarity NPC195290
0.8571 High Similarity NPC204450
0.8556 High Similarity NPC474218
0.8542 High Similarity NPC107243
0.8542 High Similarity NPC57416
0.8542 High Similarity NPC469432
0.8539 High Similarity NPC69279
0.8539 High Similarity NPC83569
0.8526 High Similarity NPC470016
0.8526 High Similarity NPC317586
0.8526 High Similarity NPC127063
0.8511 High Similarity NPC206810
0.8511 High Similarity NPC472942
0.8511 High Similarity NPC214697
0.8495 Intermediate Similarity NPC273621
0.8495 Intermediate Similarity NPC477872
0.8495 Intermediate Similarity NPC7260
0.8495 Intermediate Similarity NPC227467
0.8495 Intermediate Similarity NPC120968
0.8495 Intermediate Similarity NPC69622
0.8495 Intermediate Similarity NPC18872
0.8495 Intermediate Similarity NPC44240
0.8495 Intermediate Similarity NPC290614
0.8495 Intermediate Similarity NPC210037
0.8485 Intermediate Similarity NPC140723
0.8485 Intermediate Similarity NPC236390
0.8478 Intermediate Similarity NPC471722
0.8462 Intermediate Similarity NPC73038
0.8462 Intermediate Similarity NPC72133
0.8454 Intermediate Similarity NPC477854
0.8444 Intermediate Similarity NPC165064
0.8444 Intermediate Similarity NPC82902
0.8438 Intermediate Similarity NPC96859
0.8438 Intermediate Similarity NPC328162
0.8438 Intermediate Similarity NPC305483
0.8438 Intermediate Similarity NPC477853
0.8438 Intermediate Similarity NPC120708
0.8427 Intermediate Similarity NPC201852
0.8421 Intermediate Similarity NPC80365
0.8421 Intermediate Similarity NPC159410
0.8416 Intermediate Similarity NPC42847
0.8416 Intermediate Similarity NPC64844
0.8404 Intermediate Similarity NPC212948
0.8404 Intermediate Similarity NPC105189
0.8404 Intermediate Similarity NPC150383
0.8404 Intermediate Similarity NPC187722
0.8404 Intermediate Similarity NPC301244
0.8387 Intermediate Similarity NPC215029
0.8387 Intermediate Similarity NPC95246
0.8387 Intermediate Similarity NPC290972
0.8387 Intermediate Similarity NPC474972
0.8387 Intermediate Similarity NPC64872
0.8387 Intermediate Similarity NPC476733
0.8387 Intermediate Similarity NPC477943
0.8387 Intermediate Similarity NPC474679
0.8387 Intermediate Similarity NPC86319
0.8387 Intermediate Similarity NPC275740
0.8387 Intermediate Similarity NPC161751
0.8387 Intermediate Similarity NPC25906
0.8387 Intermediate Similarity NPC128496
0.8384 Intermediate Similarity NPC22388
0.8384 Intermediate Similarity NPC234892
0.8384 Intermediate Similarity NPC293753
0.837 Intermediate Similarity NPC167877
0.837 Intermediate Similarity NPC96496
0.837 Intermediate Similarity NPC477926
0.837 Intermediate Similarity NPC317590
0.837 Intermediate Similarity NPC136548
0.8367 Intermediate Similarity NPC316964
0.8367 Intermediate Similarity NPC218383
0.8367 Intermediate Similarity NPC154072
0.8351 Intermediate Similarity NPC320306
0.8351 Intermediate Similarity NPC475894
0.8351 Intermediate Similarity NPC190554
0.8351 Intermediate Similarity NPC108078
0.8333 Intermediate Similarity NPC312480
0.8333 Intermediate Similarity NPC279974
0.8333 Intermediate Similarity NPC255809
0.8333 Intermediate Similarity NPC472485
0.8333 Intermediate Similarity NPC88310
0.8317 Intermediate Similarity NPC278628
0.8317 Intermediate Similarity NPC231530
0.8316 Intermediate Similarity NPC134826
0.8316 Intermediate Similarity NPC475255
0.8316 Intermediate Similarity NPC25750
0.8316 Intermediate Similarity NPC158059
0.8316 Intermediate Similarity NPC250575
0.8316 Intermediate Similarity NPC477855
0.8316 Intermediate Similarity NPC202728
0.8316 Intermediate Similarity NPC229281
0.8316 Intermediate Similarity NPC118519
0.8315 Intermediate Similarity NPC38350
0.8315 Intermediate Similarity NPC473420
0.8315 Intermediate Similarity NPC201912
0.83 Intermediate Similarity NPC55872
0.8298 Intermediate Similarity NPC291028
0.8298 Intermediate Similarity NPC171441
0.8298 Intermediate Similarity NPC193750
0.8298 Intermediate Similarity NPC20388
0.8298 Intermediate Similarity NPC130278
0.8298 Intermediate Similarity NPC191684
0.8295 Intermediate Similarity NPC196827
0.8295 Intermediate Similarity NPC274996
0.8283 Intermediate Similarity NPC474327
0.8283 Intermediate Similarity NPC99411
0.828 Intermediate Similarity NPC328313
0.828 Intermediate Similarity NPC182797
0.828 Intermediate Similarity NPC131470
0.828 Intermediate Similarity NPC470542
0.828 Intermediate Similarity NPC44181
0.828 Intermediate Similarity NPC474719
0.828 Intermediate Similarity NPC471724
0.828 Intermediate Similarity NPC143767
0.828 Intermediate Similarity NPC52169
0.8265 Intermediate Similarity NPC194196
0.8265 Intermediate Similarity NPC10364
0.8265 Intermediate Similarity NPC471717
0.8265 Intermediate Similarity NPC197386
0.8261 Intermediate Similarity NPC2783
0.8261 Intermediate Similarity NPC473226
0.8261 Intermediate Similarity NPC474970
0.8261 Intermediate Similarity NPC6979
0.8261 Intermediate Similarity NPC469994
0.8261 Intermediate Similarity NPC325594
0.8261 Intermediate Similarity NPC89077
0.8247 Intermediate Similarity NPC471153
0.8247 Intermediate Similarity NPC250757

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC222845 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8602 High Similarity NPD5281 Approved
0.8602 High Similarity NPD5284 Approved
0.8511 High Similarity NPD6399 Phase 3
0.8317 Intermediate Similarity NPD6675 Approved
0.8317 Intermediate Similarity NPD7128 Approved
0.8317 Intermediate Similarity NPD5739 Approved
0.8317 Intermediate Similarity NPD6402 Approved
0.8316 Intermediate Similarity NPD4202 Approved
0.8261 Intermediate Similarity NPD3618 Phase 1
0.8252 Intermediate Similarity NPD6372 Approved
0.8252 Intermediate Similarity NPD6373 Approved
0.8242 Intermediate Similarity NPD4786 Approved
0.8191 Intermediate Similarity NPD5328 Approved
0.8163 Intermediate Similarity NPD4755 Approved
0.8155 Intermediate Similarity NPD6881 Approved
0.8155 Intermediate Similarity NPD7320 Approved
0.8155 Intermediate Similarity NPD6899 Approved
0.8152 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD6650 Approved
0.8095 Intermediate Similarity NPD6649 Approved
0.8065 Intermediate Similarity NPD5279 Phase 3
0.8058 Intermediate Similarity NPD5697 Approved
0.8058 Intermediate Similarity NPD5701 Approved
0.8043 Intermediate Similarity NPD3133 Approved
0.8043 Intermediate Similarity NPD3666 Approved
0.8043 Intermediate Similarity NPD3665 Phase 1
0.8022 Intermediate Similarity NPD3667 Approved
0.8021 Intermediate Similarity NPD8035 Phase 2
0.8021 Intermediate Similarity NPD7515 Phase 2
0.8021 Intermediate Similarity NPD8034 Phase 2
0.8021 Intermediate Similarity NPD6079 Approved
0.8 Intermediate Similarity NPD7102 Approved
0.8 Intermediate Similarity NPD5286 Approved
0.8 Intermediate Similarity NPD7290 Approved
0.8 Intermediate Similarity NPD4700 Approved
0.8 Intermediate Similarity NPD6883 Approved
0.8 Intermediate Similarity NPD4696 Approved
0.8 Intermediate Similarity NPD5285 Approved
0.7981 Intermediate Similarity NPD6011 Approved
0.798 Intermediate Similarity NPD6084 Phase 2
0.798 Intermediate Similarity NPD6083 Phase 2
0.7959 Intermediate Similarity NPD5695 Phase 3
0.7925 Intermediate Similarity NPD8130 Phase 1
0.7925 Intermediate Similarity NPD6617 Approved
0.7925 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7925 Intermediate Similarity NPD6869 Approved
0.7925 Intermediate Similarity NPD6847 Approved
0.7921 Intermediate Similarity NPD5223 Approved
0.7905 Intermediate Similarity NPD6014 Approved
0.7905 Intermediate Similarity NPD6012 Approved
0.7905 Intermediate Similarity NPD6013 Approved
0.7879 Intermediate Similarity NPD4697 Phase 3
0.7872 Intermediate Similarity NPD5280 Approved
0.7872 Intermediate Similarity NPD7521 Approved
0.7872 Intermediate Similarity NPD4694 Approved
0.7872 Intermediate Similarity NPD7334 Approved
0.7872 Intermediate Similarity NPD6409 Approved
0.7872 Intermediate Similarity NPD7146 Approved
0.7872 Intermediate Similarity NPD5330 Approved
0.7872 Intermediate Similarity NPD6684 Approved
0.785 Intermediate Similarity NPD6882 Approved
0.785 Intermediate Similarity NPD8297 Approved
0.7843 Intermediate Similarity NPD5226 Approved
0.7843 Intermediate Similarity NPD5225 Approved
0.7843 Intermediate Similarity NPD5211 Phase 2
0.7843 Intermediate Similarity NPD5224 Approved
0.7843 Intermediate Similarity NPD4633 Approved
0.7835 Intermediate Similarity NPD6050 Approved
0.7812 Intermediate Similarity NPD4753 Phase 2
0.7802 Intermediate Similarity NPD7525 Registered
0.78 Intermediate Similarity NPD7902 Approved
0.7778 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7767 Intermediate Similarity NPD4754 Approved
0.7767 Intermediate Similarity NPD5175 Approved
0.7767 Intermediate Similarity NPD5174 Approved
0.7732 Intermediate Similarity NPD5207 Approved
0.7732 Intermediate Similarity NPD5692 Phase 3
0.7723 Intermediate Similarity NPD5696 Approved
0.7723 Intermediate Similarity NPD7638 Approved
0.7708 Intermediate Similarity NPD6903 Approved
0.7708 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.77 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.77 Intermediate Similarity NPD5222 Approved
0.77 Intermediate Similarity NPD5221 Approved
0.7692 Intermediate Similarity NPD5141 Approved
0.7677 Intermediate Similarity NPD7748 Approved
0.7667 Intermediate Similarity NPD6116 Phase 1
0.7653 Intermediate Similarity NPD6411 Approved
0.7653 Intermediate Similarity NPD5694 Approved
0.7647 Intermediate Similarity NPD7640 Approved
0.7647 Intermediate Similarity NPD7639 Approved
0.7634 Intermediate Similarity NPD4223 Phase 3
0.7634 Intermediate Similarity NPD4221 Approved
0.7624 Intermediate Similarity NPD5173 Approved
0.7619 Intermediate Similarity NPD6008 Approved
0.7619 Intermediate Similarity NPD4768 Approved
0.7619 Intermediate Similarity NPD4767 Approved
0.7615 Intermediate Similarity NPD4632 Approved
0.76 Intermediate Similarity NPD4629 Approved
0.76 Intermediate Similarity NPD5210 Approved
0.7579 Intermediate Similarity NPD5329 Approved
0.7556 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7556 Intermediate Similarity NPD6117 Approved
0.7526 Intermediate Similarity NPD6672 Approved
0.7526 Intermediate Similarity NPD5737 Approved
0.75 Intermediate Similarity NPD6098 Approved
0.75 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5690 Phase 2
0.75 Intermediate Similarity NPD6335 Approved
0.75 Intermediate Similarity NPD7900 Approved
0.7477 Intermediate Similarity NPD4729 Approved
0.7477 Intermediate Similarity NPD6274 Approved
0.7477 Intermediate Similarity NPD5128 Approved
0.7477 Intermediate Similarity NPD4730 Approved
0.7474 Intermediate Similarity NPD3668 Phase 3
0.7474 Intermediate Similarity NPD4197 Approved
0.7449 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.7449 Intermediate Similarity NPD6673 Approved
0.7449 Intermediate Similarity NPD6080 Approved
0.7449 Intermediate Similarity NPD6101 Approved
0.7449 Intermediate Similarity NPD6904 Approved
0.7444 Intermediate Similarity NPD7339 Approved
0.7444 Intermediate Similarity NPD6942 Approved
0.7434 Intermediate Similarity NPD7100 Approved
0.7434 Intermediate Similarity NPD7101 Approved
0.7411 Intermediate Similarity NPD6009 Approved
0.7411 Intermediate Similarity NPD6317 Approved
0.7391 Intermediate Similarity NPD6118 Approved
0.7391 Intermediate Similarity NPD6115 Approved
0.7391 Intermediate Similarity NPD6114 Approved
0.7391 Intermediate Similarity NPD6697 Approved
0.7374 Intermediate Similarity NPD4096 Approved
0.7368 Intermediate Similarity NPD4788 Approved
0.7345 Intermediate Similarity NPD6314 Approved
0.7345 Intermediate Similarity NPD6313 Approved
0.734 Intermediate Similarity NPD4139 Approved
0.734 Intermediate Similarity NPD4692 Approved
0.7339 Intermediate Similarity NPD5135 Approved
0.7339 Intermediate Similarity NPD5247 Approved
0.7339 Intermediate Similarity NPD5251 Approved
0.7339 Intermediate Similarity NPD5249 Phase 3
0.7339 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7339 Intermediate Similarity NPD5250 Approved
0.7339 Intermediate Similarity NPD5169 Approved
0.7339 Intermediate Similarity NPD4634 Approved
0.7339 Intermediate Similarity NPD5248 Approved
0.7333 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7327 Intermediate Similarity NPD6001 Approved
0.732 Intermediate Similarity NPD4693 Phase 3
0.732 Intermediate Similarity NPD4138 Approved
0.732 Intermediate Similarity NPD4689 Approved
0.732 Intermediate Similarity NPD4690 Approved
0.732 Intermediate Similarity NPD5205 Approved
0.732 Intermediate Similarity NPD4688 Approved
0.7304 Intermediate Similarity NPD6909 Approved
0.7304 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.7304 Intermediate Similarity NPD6908 Approved
0.7273 Intermediate Similarity NPD5217 Approved
0.7273 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD5215 Approved
0.7273 Intermediate Similarity NPD5127 Approved
0.7273 Intermediate Similarity NPD5216 Approved
0.7257 Intermediate Similarity NPD7115 Discovery
0.7255 Intermediate Similarity NPD5654 Approved
0.7234 Intermediate Similarity NPD5368 Approved
0.7234 Intermediate Similarity NPD4748 Discontinued
0.7228 Intermediate Similarity NPD5133 Approved
0.7222 Intermediate Similarity NPD6412 Phase 2
0.7217 Intermediate Similarity NPD6319 Approved
0.7204 Intermediate Similarity NPD5784 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD5362 Discontinued
0.7179 Intermediate Similarity NPD7604 Phase 2
0.7172 Intermediate Similarity NPD5208 Approved
0.7172 Intermediate Similarity NPD4518 Approved
0.7168 Intermediate Similarity NPD6868 Approved
0.7158 Intermediate Similarity NPD5369 Approved
0.7155 Intermediate Similarity NPD5983 Phase 2
0.7143 Intermediate Similarity NPD6926 Approved
0.7143 Intermediate Similarity NPD6924 Approved
0.7143 Intermediate Similarity NPD5733 Approved
0.7143 Intermediate Similarity NPD6404 Discontinued
0.7129 Intermediate Similarity NPD5693 Phase 1
0.7119 Intermediate Similarity NPD7492 Approved
0.7115 Intermediate Similarity NPD5959 Approved
0.7111 Intermediate Similarity NPD4243 Approved
0.71 Intermediate Similarity NPD6051 Approved
0.7083 Intermediate Similarity NPD4270 Approved
0.7083 Intermediate Similarity NPD6435 Approved
0.7083 Intermediate Similarity NPD4269 Approved
0.708 Intermediate Similarity NPD5167 Approved
0.7069 Intermediate Similarity NPD6054 Approved
0.7069 Intermediate Similarity NPD6059 Approved
0.7059 Intermediate Similarity NPD5779 Approved
0.7059 Intermediate Similarity NPD6616 Approved
0.7059 Intermediate Similarity NPD5778 Approved
0.7059 Intermediate Similarity NPD6336 Discontinued
0.7009 Intermediate Similarity NPD7632 Discontinued
0.7 Intermediate Similarity NPD5168 Approved
0.7 Intermediate Similarity NPD7078 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data